Hypothalamic, Pituitary, and Adrenal Disorders Articles

• The Dietary Inflammatory Index is Associated With PCOS A new study looks at the potential link between the dietary inflammatory index and the risk of developing PCOS.
  Clinical Endocrinology, May 20, 2022
• Combating Stress and Tackling Cortisol With increasing stressors, controlling the stress hormone cortisol is more vital than before. Dr Guttenberg offers insight into the body's response to stress and tips on how to combat it.
  Endocrine Society, May 17, 2022
• Therapy Adherence and QoL in Congenital Adrenal Hyperplasia Does better adherence to therapy regimens translate to a higher quality of life among patients with congenital adrenal hyperplasia?
  Clinical Endocrinology, May 06, 2022
• Prevalence of Primary Aldosteronism in T2D and Hypertension How prevalent is primary aldosteronism among patients with type 2 diabetes and hypertension? Should routine screening be considered for these patients?
  Clinical Endocrinology, May 05, 2022
• Adrenal Insufficiency: Prevalence and Healthcare Utilization Using administrative health data, a new study examines the prevalence of adrenal insufficiency and the rates of healthcare utilization for this condition.
  Journal of the Endocrine Society, April 21, 2022
• What Insight Does Big Data Offer Into Adrenal Insufficiency? Large, searchable clinical databases allow us to track outcomes in greater numbers of patients with adrenal insufficiency, but not without a few glitches, notes Dr Plotzker.
  Medscape Diabetes & Endocrinology, April 08, 2022
• Female Adult Acne and Androgen Excess Find out more about the relationship between adult female acne and androgen excess -- and learn how to effectively diagnose and treat these patients.
  Journal of the Endocrine Society, April 05, 2022
• TLC599 in Patients With Osteoarthritis of the Knee TLC599, a newly developed injectable treatment, may be a safe and effective pain management option for knee osteoarthritis.
  Arthritis Research & Therapy, April 04, 2022
• Characteristics, Comorbidities and Testosterone Prescribing Certain factors may impact the decision of whether or not to prescribe testosterone replacement therapy. What are they?
  Clinical Endocrinology, March 24, 2022
• Pregnancy Doesn't Boost Cushing Disease Recurrences Data from 113 young women in remission from Cushing disease after pituitary surgery showed that subsequent pregnancy had no apparent effect on recurrence rate.
  First Look, March 22, 2022
• Perioperative Management of a Patient With Cushing Disease The perioperative management of patients with Cushing disease is complex and requires a multidisciplinary approach. Find out what there is to know.
  Journal of the Endocrine Society, March 22, 2022
• Fibrin Clots and Fibrinolysis in Endocrine Hypertension Are altered fibrin clot properties and impaired fibrinolysis associated with a higher risk of cardiovascular events in these patients?
  Clinical Endocrinology, March 10, 2022
• In California Nursing Homes, Omicron Is Bad. So Is the Isolation. The latest visitor restrictions and testing requirements are compounding the isolation that residents have suffered for almost 2 years.
  Kaiser Health News, January 31, 2022
• Hyponatremia in Patients on Immune Checkpoint Inhibitors Patients treated with immune checkpoint inhibitors may realize a greater risk for developing hyponatremia and other electrolyte disorders. How common are these events?
  Nephrology Dialysis Transplantation, January 18, 2022
• Periprosthetic Distal Femur Fracture Management Differences A survey of trauma and arthroplasty surgeons finds notable differences in treatment recommendations for periprosthetic distal femur fractures.
  Journal of the American Academy of Orthopaedic Surgeons, January 10, 2022
• Diagnosing Adrenal Insufficiency With Modern Cortisol Assays A new study examines the validity of newer assays for the diagnosis of adrenal insufficiency, particularly when considering hospitalization and opioid exposure.
  Clinical Endocrinology, January 06, 2022
• Alert FDA Approves Levoketoconazole for Cushing Syndrome The drug, which inhibits cortisol synthesis, is seen as addressing an unmet need.
  FDA Approvals, January 04, 2022
• Benign Adrenal Tumors Linked to Hypertension, Type 2 Diabetes Benign adrenal tumors produce enough cortisol to cause hypertension or type 2 diabetes in more than 15% of patients in a prospective UK study.
  Medscape Medical News, January 03, 2022
• Alert Oral Steroid Gets FDA Approval for IgA Nephropathy Oral budesonide delayed-release (Tarpeyo) became the first agent to receive FDA approval for reducing proteinuria in patients with primary IgA nephropathy and at risk for rapid progression.
  FDA Approvals, December 17, 2021
• Evaluation of a Difference or Disorder of Sex Development This article provides updated guidance regarding the evaluation of a child or adolescent who presents with a suspected difference or disorder of sex development.
  Clinical Endocrinology, December 16, 2021